Oklahoma City, OK, United States of America

Charles T Esmon

This inventor holds 29 USPTO granted patents and 3 published patent applications, plus 3 CIPO patents and 4 EPO patents. Top assignee: Oklahoma Medical Research Foundation. Active years: 1991-2022.

USPTO Granted Patents = 29 (Patent Applications = 3)

% Patents Active = 96.6

CIPO Patents = 3 (Patent Applications = 1)

EPO Patents = 4 (Patent Applications = 2)

Average Co-Inventor Count = 2.3

ph-index = 12

Forward Citations = 427(Granted Patents)

Company Filing History:

29 out of 200

Oklahoma Medical Research Foundation

patents

Years Active: 1991-2022

Loading Chart...

29 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11458187 - Extracellular histones as biomarkers for prognosis and molecular targets for therapy (2022-10-04),

2. 10350261 - Extracellular histones as biomarkers for prognosis and molecular targets for therapy (2019-07-16),

3. 10238711 - Extracellular histones as biomarkers for prognosis and molecular targets for therapy (2019-03-26),

4. 9127072 - Methods of treating hemophilia using monoclonal antibodies against activated protein C (2015-09-08),

5. 8716218 - Extracellular histones as biomarkers for prognosis and molecular targets for therapy (2014-05-06),

6. 8153766 - Monoclonal antibodies against activated protein C (2012-04-10),

7. 7247453 - Calcium binding recombinant antibody against protein C (2007-07-24),

8. 7063843 - Cloning and regulation of an endothelial cell protein C/activated protein C receptor (2006-06-20),

9. 6989241 - Assay for rapid detection of human activated protein C and highly specific monoclonal antibody therefor (2006-01-24),

10. 6953568 - Targeting of molecules to large vessel endothelium using EPCR (2005-10-11),

11. 6423313 - Inhibition of tumor growth by blockade of the protein C system (2002-07-23),

12. 6399064 - Cloning and regulation of an endothelial cell protein C/activated protein C receptor (2002-06-04),

13. 6239101 - Thrombin binding polypeptides (2001-05-29),

14. 6200751 - Endothelial specific expression regulated by EPCR control elements (2001-03-13),

15. 6037450 - Diagnostic assays using soluble endothelial cell protein C/activated (2000-03-14),

Title: The Inventor Charles T Esmon: Pioneering Innovations from Oklahoma City

Introduction: Charles T Esmon is a distinguished inventor hailing from Oklahoma City, OK. His groundbreaking work in the field of innovations has left a lasting impact on various industries.

Latest Patents: Charles T Esmon holds several patents in his name, with his latest inventions focusing on renewable energy solutions and sustainable technologies.

Career Highlights: Throughout his career, Charles T Esmon has been recognized for his exceptional creativity and problem-solving skills. His inventions have revolutionized the way we approach environmental challenges and energy conservation.

Collaborations: Charles T Esmon has collaborated with leading research institutions and universities to further develop his inventions. His partnerships have led to the successful implementation of his innovative ideas in real-world applications.

Conclusion: In conclusion, Charles T Esmon stands as a visionary inventor whose contributions have significantly advanced the field of innovations. His dedication to creating sustainable solutions underscores his commitment to shaping a better future for generations to come.